[PRNewswire] Sai Life Sciences, Schrodinger와 전략적 계약 체결

-- 인도에 Schrodinger의 첫 해외 전용 연구 실험실 설립

(하이데라바드, 인도 2023년 1월 11일 PRNewswire=연합뉴스) 인도에서 가장 빠르게 성장하는 세계적인 의약품 위탁연구 및 위탁개발생산 기업(CRO/CDMO) 중 하나인 Sai Life Sciences[https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]가 인도 하이데라바드에 SaiSchrodinger Research Laboratories(SSRL)를 설립하기 위해 Schrodinger와 5년 기간의 전략적 계약을 체결했다고 발표했다. Schrodinger는 물리 기반 전산 플랫폼으로 치료제와 소재를 발견하는 방식을 변혁시키고 있다.

SSRL은 하이데라바드 게놈 밸리에 위치한 Sai Life Sciences의 연구개발 캠퍼스에 들어설 예정이다. SSRL은 의약 및 합성 화학[https://www.sailife.com/services/discovery/synthetic-medicinal-chemistry/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ], 시험관 생물학[https://www.sailife.com/services/discovery/biology/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] 및 프로세스 화학[https://www.sailife.com/services/development/process-familiarisation/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]을 포함하는 통합적인 발견 작업의 흐름을 위한 전용 시설로 기능할 전망이다. 또한, SSRL은 필요에 따라 시험관 ADME[https://www.sailife.com/services/discovery/dmpk-in-vitro-adme/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]와 체내 PK[https://www.sailife.com/services/discovery/dmpk-in-vivo-pk/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]와 같은 회사의 다른 역량도 활용할 예정이다. 이번 계약은 Schrodinger의 입증된 전산 플랫폼을 활용하는 프로그램 발전도 지원하게 된다.

이번 발표를 통해, Sai Life Sciences CEO 겸 전무이사 Krishna Kanumuri는 "자사의 첫 해외 연구소를 설립하기 위해 양사가 협력하게 된 것을 진심으로 기쁘게 생각한다"라며, "다양한 측면에서 볼 때, 이는 통합적인 신약 개발[https://www.sailife.com/services/discovery/integrated-drug-discovery-services/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] 역량의 규모, 범위 및 깊이 측면에서 자사가 이룬 발전을 보여주는 증거"라고 말했다. 이어 "Schrodinger 팀과의 협력에 크게 기대하고 있으며, 브랜드 약속을 바탕으로 함께 개선해가고자 노력할 것"이라고 덧붙였다.

올 4월 개관 예정인 SSRL은 의약 화학, 생물학, 프로세스 화학, 분석 화학 및 기타 지원 직원에 걸쳐 풀타임 근로자(Full-Time-Equivalent, FTE)를 기준으로 약 75명을 우선 채용할 예정이다. SSRL 직원 채용은 이미 시작됐으며, 채용공고는 여기[https://www.sailife.com/current-openings-at-the-sai-schrodinger-research-laboratories/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab]에서 확인할 수 있다.

Sai Life Sciences의 신약 사업[https://www.sailife.com/services/discovery/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]은 최근 수년 동안 변혁적인 성장 단계를 거쳤으며, 이는 확장 중인 고객 믹스와 프로그램의 다양성에서 확인할 수 있다. 보스턴과 하이데라바드 전역에서 인재, 기술 및 역량 투자를 기반으로 하는 Sai Life Sciences의 글로벌 전달 모델은 최적화된 인재, 속도 및 비용 효율성의 조합으로 고객에게 고유의 가치를 제공하고 있다. 이 여정은 통상 보스턴에 위치한 Sai Life Sciences의 탐색 생물학 시설[https://www.sailife.com/boston-usa/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]에서 시작된다. 이곳에서 Sai Life Sciences는 아웃소싱이 어려운 조기 발견 생물학 프로그램에서 고객과 실시간으로 협력한다. 이후 이들 프로그램은 Sai Life Sciences의 하이데라바드 연구개발 캠퍼스[https://www.sailife.com/research-technology-centre-hyderabad/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]로 전환되고, 이 통합적인 단일 캠퍼스에서 화학, 생물학 및 ADME-PK 서비스를 강화한다. 그에 따라 회사의 과학자들은 팀으로 작업하며, 고객에게 고품질 데이터를 제공할 수 있다.

Sai Life Sciences 소개

Sai Life Sciences는 저분자 발견, 개발 및 상업화를 가속화하기 위해 전 세계적으로 혁신적인 제약 및 생명공학 기업과 협력하는 풀-서비스 CRO-CDMO[https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]다. Sai Life Sciences는 고객의 출시 일정을 단축시킬 수 있는 고품질의 비용 효과적인 솔루션을 제공하고자 민첩하고 창의적인 접근법을 취한다. Sai Life Sciences는 TPG Capital과 HBM Healthcare Investments 같은 세계적인 투자사의 지원을 받고 있다. Sai Life Sciences는 오늘날 전 세계 200개 이상의 혁신 기업과 협력하고 있으며, 인도, 영국 및 미국 내 자사 시설에서 2천500명 이상의 직원을 보유하고 있다. https://www.sailife.com/

사진: https://mma.prnewswire.com/media/1980494/SSRL_India.jpg

Sai Life Sciences inks strategic agreement to set up Schrodinger's first dedicated offshore Research Laboratories in India

로고: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg

Sai Life Sciences Logo

출처: Sai Life Sciences

Sai Life Sciences inks strategic agreement to set up Schrodinger's first dedicated offshore Research Laboratories in India

HYDERABAD, India, Jan. 10, 2023 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrodinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the SaiSchrodinger Research Laboratories (SSRL) in Hyderabad, India.

Being built inside Sai Life Sciences' R&D campus in genome valley, Hyderabad, SSRL will be a dedicated facility for integrated discovery work streams including medicinal & synthetic chemistry [https://www.sailife.com/services/discovery/synthetic-medicinal-chemistry/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ], in vitro biology [https://www.sailife.com/services/discovery/biology/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ], and process chemistry [https://www.sailife.com/services/development/process-familiarisation/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ]. It will access other Sai capabilities such as in vitro ADME [https://www.sailife.com/services/discovery/dmpk-in-vitro-adme/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] and in vivo PK [https://www.sailife.com/services/discovery/dmpk-in-vivo-pk/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] as needed. The relationship will support advancement of programs that leverage Schrodinger's validated computational platform.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said, "We're truly delighted that Schrodinger has decided to partner with Sai Life Sciences to set-up their first offshore research laboratories. In many ways, this is a testimony to the advances we have made in the scale, scope and depth of our integrated drug discovery [https://www.sailife.com/services/discovery/integrated-drug-discovery-services/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] capabilities. We are very excited about working with the Schrodinger team and, guided by our brand promise, will strive to make it better together."

Scheduled to open in April 2023, SSRL will commence with about 75 staff members, across full-time-equivalents (FTEs) in Medicinal Chemistry, Biology, Process Chemistry, Analytical Chemistry, and other support staff. Recruitment has commenced for SSRL, and the open positions can be viewed here [https://www.sailife.com/current-openings-at-the-sai-schrodinger-research-laboratories/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ].

The Discovery business [https://www.sailife.com/services/discovery/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] of Sai Life Sciences has been witnessing a transformative phase of growth in recent years, as is evidenced in its expanding client mix and diversity of programs. Powered by investments in talent, technology and capacity across Boston and Hyderabad, the company's global delivery model is delivering unique value to its customers through an optimal blend of talent, speed, and cost efficiency. This journey typically starts with its exploratory biology facility [https://www.sailife.com/boston-usa/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] in Boston, where the company works hand-in-hand with clients in real-time on early discovery biology programs that are difficult to outsource. These programs then transition to the company's Hyderabad R&D campus [https://www.sailife.com/research-technology-centre-hyderabad/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ], where it has consolidated its chemistry, biology and ADME-PK services in one integrated campus, allowing Sai scientists to work as teams and deliver quality data to its customers.

About Sai Life Sciences

Sai Life Sciences is a full-service CRO-CDMO [https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=schrodinger-offshore-research-lab ] that works with innovator pharma and biotech companies globally, to accelerate the discovery, development and commercialisation of small molecules. It takes a nimble and creative approach to deliver high-quality, cost-effective solutions for its clients that accelerate their time to market. Backed by global investors, TPG Capital and HBM Healthcare Investments, the company today works with over 200 innovator companies globally and has over 2500 employees across its facilities in India, UK and USA. https://www.sailife.com/

Photo: https://mma.prnewswire.com/media/1980494/SSRL_India.jpg

Sai Life Sciences inks strategic agreement to set up Schr?dinger's first dedicated offshore Research Laboratories in India

Logo: https://mma.prnewswire.com/media/1044186/Sai_Life_Sciences_Logo.jpg

Sai Life Sciences Logo

Source: Sai Life Sciences

[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.

(끝)

출처 : PRNewswire 보도자료